Sharnette Miles
Podiatrist · Baton Rouge, LANPI 1154674810
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,822 of the $7,346 with a category attached, or 65.6%. Smith+Nephew accounts for 61.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $3,115 and has fallen 77.7% since, to $693 in 2025.
Across 123 payments — averaging $59.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$5K
- Kerecis Limited$815
- Organogenesis Inc.$739
- Mimedx Group, Inc.$278
- Stryker$270
- Baxter Healthcare$257
- plus $476 from 4 others
What the payments were for
- Travel & lodging$2,52334%
- Food & beverage$4,82266%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 83 | $4,511 |
| Kerecis Limited | 6 | $815 |
| Organogenesis Inc. | 23 | $739 |
| Mimedx Group, Inc. | 2 | $278 |
| Stryker | 3 | $270 |
| Baxter Healthcare | 2 | $257 |
| Biocomposites Inc | 1 | $171 |
| Integra Lifesciences Corporation | 1 | $154 |
| Nevro Corp. | 1 | $134 |
| Bioventus LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Versajet$2,724
- PICO$2,277
- Grafix$1,676
- Kerecis Omega3 Marigen$1,520
- RENASYS TOUCH$1,219
- Kerecis Omega3 SurgiClose$1,173
- ACTICOAT 4" X 4"$933
- Allevyn Gentle Border 10 x 10cm Ctn 10$933
- Oasis$933
- Kerecis Omega3 GraftGuide$673
- INTEGRA$463
- Stimulan$171
- INTEGRA DERMAL REGENERATION TEMPLATE$154
- PRIMATRIX$154
- AUGMENT INJECTABLE$150
- Omnia$134
- ACTICOAT$125
- Renasys$125
- Leaf$125
- Stravix$125
How this compares
$7,346 in reported general payments places this provider in the 80th percentile of 68 podiatrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 149 | $3,544 |
| Pregabalin | 147 | $1,407 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 31 | $1,371 |
| Gabapentin | 124 | $843 |
| Ketoconazole | 42 | $825 |
| Mupirocin | 86 | $783 |
| Terbinafine Hcl | 47 | $718 |
| Methylprednisolone | 95 | $655 |
| Colchicine | 51 | $469 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $343 |
| Diclofenac Sodium | 18 | $343 |
| Allopurinol | 51 | $303 |
| Ammonium Lactate | 15 | $292 |
| Methocarbamol | 39 | $211 |
| Triamcinolone Acetonide | 34 | $197 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Baton Rouge
- Chima AkunneBaton Rouge$7K
- Irene EvuleochaBaton Rouge$6K
- Carey CliftonBaton Rouge$5K
- Christopher FormanekBaton Rouge$4K
- Zachary RohrBaton Rouge$4K
- Joseph TullierBaton Rouge$325
- Elina DoueniasBaton Rouge$235
- Maxime SavardKenner$74K
- David TranMonroe$24K
- Tyler TewilliagerHouma$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.